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Abstract 
Purpose: Frailty is a valuable predictor for outcome in elderly ICU patients, and has been suggested to be used in 
various decision-making processes prior to and during an ICU admission. There are many instruments developed 
to assess frailty, but few of them can be used in emergency situations. In this setting the clinical frailty scale (CFS) is 
frequently used. The present study is a sub-study within a larger outcome study of elderly ICU patients in Europe (the 
VIP-2 study) in order to document the reliability of the CFS.
Materials and methods: From the VIP-2 study, 129 ICUs in 20 countries participated in this sub-study. The patients 
were acute admissions ≥ 80 years of age and frailty was assessed at admission by two independent observers using 
the CFS. Information was obtained from the patient, if not feasible, from the family/caregivers or from hospital files. 
The profession of the rater and source of data were recorded along with the score. Interrater variability was calculated 
using linear weighted kappa analysis.
Results: 1923 pairs of assessors were included and background data of patients were similar to the whole cohort 
(n = 3920). We found a very high inter-rater agreement (weighted kappa 0.86), also in subgroup analyses. The agree-
ment when comparing information from family or hospital records was better than using only direct patient informa-
tion, and pairs of raters from same profession performed better than from different professions.
Conclusions: Overall, we documented a high reliability using CFS in this setting. This frailty score could be used more 
frequently in elderly ICU patients in order to create a more holistic and realistic impression of the patient´s condition 
prior to ICU admission.
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Background
Frailty assessment is increasingly used in critically ill 
elderly patients and has in many studies been shown 
to correlate with outcomes [1–3]. Frailty assessment 
has recently been suggested as one of several ele-
ments that could theoretically considered for decision 
to admit patients to the ICU during the present pan-
demic [4], although firm evidence for its use is lacking. 
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Traditionally, frailty assessments are performed within 
the context of a comprehensive geriatric assessment and 
require active participation from the patient [5]. Under-
standably, this is not feasible in most acutely admitted or 
critical ill patients, and hence other methods have been 
developed to overcome this problem. One of the most 
frequently used tool for frailty assessments in this set-
ting is the Clinical Frailty Scale (CFS) [6] developed from 
the large Canadian studies of frailty that established the 
cumulative deficit approach to frailty. The CFS has since 
increasingly been used in intensive care as well as in 
other emergency settings and was found in a recent sys-
tematic review to be the most frequent instrument used 
to assess frailty in ICU patients, but is only properly vali-
dated in patients ≥ 65 years [7].
As in any assessment method, the psychometric prop-
erties of the test are important. Regarding the CFS, the 
original publication [6] established construct validity by 
comparing it with the frailty index [8]. Inter-rater reli-
ability of the CFS has been tested in a limited number 
of patients in three studies [9–11] and the feasibility was 
clinically demonstrated in the VIP1 study where CFS was 
collected in 99.8% of the 5187 patients included [1]. As a 
pre-defined sub-study nested within the VIP2 study [12] 
we additionally planned to perform a large international 
assessment of CFS reliability.
Interrater variability may vary for several reasons: indi-
vidual differences in how to use the CFS, the rater’s pro-
fession and experience, and the source of information 
necessary to perform a frailty score. Our hypothesis is 
that the CFS, being intuitive to perform, may vary little 
with the rater’s profession and source of available infor-
mation to perform the score.
The main aim of this study was to document inter-rater 
reliability within a large prospective observation study 
and assess the results of the score being derived from dif-
ferent raters and dissimilar information source, and in 
addition study potential variances between countries.
Methods
Study design and setting
The observational VIP-2 study was performed in acute 
ICU admissions of patients ≥ 80  years, and its primary 
aim was to describe the influence and interaction of sev-
eral geriatric syndromes: frailty, co-morbidity, the activity 
of daily life, and cognition on many different outcomes. 
The study was performed over 12 months in 2018–2019 
and included 3920 patients from 22 countries. More 
details and results can be found in the original publica-
tion [12]. Units could voluntarily sign up additionally to 
participate in a pre-defined sub-study of the inter-rater 
variability of CFS. The English version of CFS was used 
except for France and Switzerland using a validated ver-
sion in French [13].
Clinical Frailty Scale (CFS)
The CFS was used to assess frailty in all recruited patients 
as it presented prior to the acute event and admission 
to the ICU. The CFS is a pictographic scale from 1–9 
describing nine different grades of frailty with a short text 
attached [6]. Patients with scores from 1 to 3 are con-
sidered not frail, 4 is pre-frail or vulnerable, and 5 to 9 
are considered to be frail. No specific training, except a 
written explanation of the use of the CFS, was given to 
the participating units where many, but not all units had 
prior experience with using it.
Assessment performed by different raters
In this study, two different study personnel from the 
ICU independently and blinded for each other results, 
assessed the patient at admission (first 24 h in the ICU) 
using the CFS with input from patients if possible, if not 
from care-givers or the medical and nursing hospital 
notes. The second rater was free to use sources of input 
and was not constrained to use the same as rater 1. The 
CFS score was noted for assessor 1 and 2 with informa-
tion about the profession of the assessor: ICU nurse, ICU 
physician, dedicated study person, or other. Furthermore, 
they documented the kind of information that was used 
to perform the score. These data were then recorded in 
the electronic case record form (CRF) for the VIP-2 study 
by the local study investigator.
The assessors were named Rater 1 and Rater 2. In the 
analysis of data, the CFS rating was considered as an 
ordinal variable, and the occupation of the assessors 
were grouped as ICU nurse; ICU physician; research 
staff or other. The main source where the information 
was obtained was classified into 4 groups: (a) from the 
patient; (b) from family/care-givers; (c) from hospital 
records; and (d); another source, and they could only 
choose one option.
Registration and ethics
This pre-defined sub-study was registered on Clinical 
Trials.gov identifier NCT03370692 at the same time as 
the main study. The main study was approved by ethical 
committees in all participating countries by institutional 
research boards, for details see the VIP-2 study main 
paper [12]. Since this study involved health profession-
als (raters) in some countries, this sub-study had to go 
through an independent review, and the rater then had to 
give informed consent to participate.
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Statistical analyses
A statistical analysis plan was discussed in the VIP2 study 
group and was decided to adopt to the guidelines for 
reporting of reliability and agreement studies (GRAAS) 
[14], see Additional file 1.
Data were analysed using SPSS version 25.0 (IBM, 
Armonk, NY USA) and with MedCalc 19.0 (http://www.
medca lc.org Ostend, Belgium). The inter-rater reliabil-
ity was assessed using linear weighted kappa in order to 
minimise outlier ratings and with intraclass correlation 
coefficient where raters for each subject were selected at 
random and with a one-way random effects model. We 
first analysed the inter-rater variability using all pairs 
then compared raters from different professions, infor-
mation sources and participating countries. In the manu-
script, we further use the accepted grouping of weighted 
kappa: Poor: 0–0.2, Fair (0.21–0.4), Moderate (0.41–0.6), 
good (0.61–0.8) and very good (0.81–1.0) [14, 15].
Results
20 countries and 129 ICUs contributed to the inter-rater 
study that included 1923 pairs of raters, and hence two 
independent CFS assessments. This represented 49.1% of 
the whole VIP-2 study population, and patients’ details 
compared to patients not studied are given in Table 1.
Overall the number of completed CFS in the VIP-2 
study was 99.6%, higher than activity of daily life score 
(ADL): 88.6% or cognition (IQCODE): 76.0%, showing 
very high compliance with this score. The profession of 
rater 1 and rater 2 were most often ICU physicians fol-
lowed by ICU nurses, and the source of information for 
the rating was most often the family/care-givers (Fig. 1). 
The mean CFS from rater 1 and 2 was 4.18 (± 1,764) and 
4.25 (± 1.76), respectively. Since the “other” group of 
raters and information sources were few and not speci-
fied, we have excluded these from further analysis.
The 9 different pairs of raters with regard to the profes-
sion are given in Table 2. The weighted kappa for all pairs 
was 0.86 (95% CI 0.84–0.87).
The intraclass correlation coefficient (absolute agree-
ment) was 0.93 for single measures and 0.96 for average 
measures, and the weighted kappa for all measures was 
0.86 (95% CI 0.84–0.87) (Table  3). Worth noting is the 
distribution of scores of 4 and 5 in Table 3. A notewor-
thy number of rater one and two have scores above and 
below these values. Among rater one, 30 of 402 (7.4%) 
scored one or more CFS classes above 4 and by rater two 
in 65 of 407 (16%) patients demonstrating some difficulty 
of judging vulnerable from frail patients.
The results in Table  4 demonstrate the variability 
between pairs from different professions and less vari-
ability when similar source for information was used for 
both pairs. The best results were obtained when both 
raters were either nurses or physicians, and mixed pairs 
of assessors performed slightly worse. Likewise, there are 
better results when information does not come from the 
patients. There is also a good performance of the CFS 
across countries, but the three countries with the least 
number of pairs included performed less well than the 
others, although most countries were overall classified as 
very good (weighted kappa ≥ 0.80).
We also performed a sensitivity analysis looking at two 
subgroups according to rater 1: frail (CFS > 4) versus non-
frail (CFS < 5). In the frail the kappa was 0.70 (95% CI 
0.66–0.74) compared to 0.76 (95% CI 0.74–0.79).
Discussion
In this large prospective study on frailty assessment in 
the ICU using the CFS, we found the overall agreement 
of inter-rater variability in patients > 80  years to be very 
good. We revealed, however, distinct variations between 
groups of raters and between countries. The agreement 
between obtaining CFS from hospital records or family 
Table 1 Details of  VIP-2 patients studied compared 
to those not studied
The CFS is the value from Rater 1, and the % relates to the column (within the 
subgroup)
SOFA sequential organ failure assessment, CFS clinical frailty scale, IQCODE 
informant questionnaire on cognitive decline in the elderly, ADL activity of daily 
living, CPS Co-morbidity and Polypharmacy score
Included Not included
Number 1923 1997
Age (median IQR) year 84 (81–87) 84 (81–87)
Male sex (%) 53.8% 53.3%
ICU LOS (median IQR) days 4 (1.96–8.89) 4 (1.71–7.12)
SOFA score (median IQR) 6 (4–9) 6 (4–9)
CFS fit (1–3) 789 (41%) 754 (38.1%)
CFS vulnerable (CFS 4) 407 (21.1%) 384 (19.4%)
CFS frail (CFS 5–9) 732 (37.8%) 840 (42.5%)
IQCODE (median, IQR) 3.25 (3–3.75) 3.19 (3–3.56)
Katz ADL score (mean) 4.8
Co-morbidity/polypharmacy 
score (mean and 95% CI
10.6 (10.4–10.9)
Admission groups (%)
 Acute respiratory failure 22.8 25.3
 Emergency surgery 15.4 12.3
 Sepsis 14.5 13.0
 Acute circulatory failure 13.8 13.8
 Respiratory and circulatory 10.7 12.2
 Trauma 6.1 4.6
 Cerebral failure 5.8 4.0
 Other 10.4 13.0
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was nearly identical but was lower when the patients were 
used as the primary source of information.
Frailty is important in order to understand critical ill 
patients, particularly in advanced age [16], and most 
studies have demonstrated a close link between frailty 
and survival. Hence, knowledge of frailty status could be 
important when issues such as ICU triage and limitation 













Source Patients Care-giver Hospital
records
Raters profession and source of information
Rater 1 Rater 2
Fig. 1 Raters profession and source of information in the two groups
Table 2 Distribution of pairs of Rater 1 versus Rater 2
a Missing pairs in 4 patients
Profession of raters Rater 1
Rater  2a ICU nurse ICU physician Research staff
ICU nurse 57 309 126
ICU physician 162 785 120
Research staff 46 96 138
Table 3 Intraclass variance Rater 1 (CFS1) and Rater 2(CFS2); weighted kappa (linear) 0.86 (0.84–0.87)
CFS 2 CFS 1
1 2 3 4 5 6 7 8 9 Sum %
1 76 3 0 1 1 0 0 0 0 81 (3.5%)
2 0 7 1 0 0 0 0 0 0 196 (14.0%)
3 2 40 403 25 7 2 0 1 0 480 (25.0%)
4 1 4 54 313 22 7 1 0 0 402 (20.9%)
5 0 0 10 58 163 28 2 0 1 262 (13.6%)
6 0 0 5 5 43 177 17 2 0 249 (12.9%)
7 0 0 0 1 2 44 126 8 0 181 (9.4%)
8 0 0 0 1 0 3 13 46 2 65 (3.4%)
9 0 0 0 0 0 0 0 0 7 7 (0.4%)
Sum % 94 (4.9%) 202 (10.5%) 493 (25.6%) 407 (21.2%) 240 (12.5%) 261 (13.6%) 159 (8.3%) 57 (3.0%) 10 (0.5%) 1923
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propose the use of frailty assessment as a part of the tri-
age process to be used with COVID-19 [17]. However, 
use of frailty in triage setting has its limitations, and is 
at present not confirmed in prospective studies. How-
ever, use of CFS would be effective in analysing the clini-
cal decision-making process of an ICU team. There are 
several methods to assess frailty, and CFS is frequently 
used in clinical studies with ICU patients [2] as well as 
in emergency admission [18] and is also used in routine 
clinical use in intensive care units outside study settings 
[19].
Using an instrument such as a frailty score requires 
knowledge about its performance and with special atten-
tion to reliability and construct validity [20]. Of interest 
is also its ability to predict risk for death, where CFS have 
been found to perform well. This was recently confirmed 
in the VIP-2 study, where CFS alone had similar predic-
tive value for 30-day mortality as a model incorporating 
cognition and functional disability [12], again providing 
good criterion validity.
The aim of the present study was to document several 
unanswered questions using CFS. What is the inter-rater 
variability when analysing more heterogeneous groups 
of raters using a various source of data for the score? 
Both aspects are important properties of a clinical test 
or score. The variation of a score in the same patient 
between two raters is the inter-rater variability. Overall, 
our data proves a very high degree of agreement between 
raters with a weighted kappa of 0.86. Since we had a large 
number of pairs to study, we could study results in sub-
groups, both between raters from different professions, 
the source of information as well as performance across 
countries. There seems to be better agreement when the 
raters are from the same profession; physicians or nurses. 
When the raters are from different professions the agree-
ment is slightly less. We also provide data showing that 
obtaining information from family members and care-
givers or from written records in order to classify CFS 
is in fact, better compared to the information obtained 
from the patient. This may have a simple explanation that 
many elderly patients, although seemingly awake and 
co-operable, may not perform at their best at the time 
of ICU admission. Hence important information may 
not be revealed for the rater. We have found that it can 
be a problem to differentiate between CFS 4 and 5. This 
could be important since 5 is the first stage on the frail 
part of the CFS and 4 is borderline. Recently the CFS was 
upgraded to version 2.0 and a more detailed guideline 
in how to understand and use the different levels in the 
scale have been published [21].
Our study is in line with three recent studies of the 
inter-rater variability of the CFS. All studies are from 
single countries with a smaller number of pairs included, 
and only the overall inter-rater variability was reported. 
In a study from Canada involving two ICUs [8], different 
assessors from a research coordinator, an occupational 
therapist, and a geriatric resident, performed CFS scores 
in 150 newly admitted ICU patients. They reported no 
significant differences between the three raters using 
Spearman’s rank correlation coefficient. In a more recent 
study from six ICUs in Wales and Scotland, 101 patients 
were studied with two independent CFS assessments of 
frailty by assessors from medical or nursing backgrounds 
[7]. They found a good agreement with a weighted kappa 
of 0.74 between raters, and also that agreement differed 
slightly depending on the assessor’s background.
A more recent study comparing CFS scored in 158 
adult ICU patients scored by geriatricians and intensiv-
ists reported however a poor agreement between raters 
[9]. The authors suggest that these two groups have a 
different conception of how frailty presents in critical ill 
patients as an explanation for this result.
Our study has its limitation: this was not a controlled 
trial with regard to the choice of profession and source 
of data used and may have been at the centres’ discre-
tion. We also have no information about the clinical 
experience of the raters nor their age. The study has also 
strengths. It has a very large sample size of nearly 2000 
pairs of raters, with at least three important sources of 
variation: the profession of raters, source of information, 
and country.
Table 4 Weighted kappa in  subgroups (physicians 
and nurses) and 8 countries (≥ 100 pairs)
Group profession N Weighted 
kappa
95% CI
ICU physician/ICU physician 785 0.87 0.85 to 0.89
ICU nurse/ICU nurse 57 0.92 0.87 to 0.97
Research staff/research staff 276 0.84 0.80 to 0.87
ICU nurse/ICU physician 162 0.77 0.71 to 0.83
ICU physician/ICU nurse 309 0.80 0.77 to 0.84
Group: information source
 Patient/patient 394 0.85 0.82–0.88
 Family/family 818 0.89 0.87–0.90
 Hospital records/hospital records 187 0.89 0.85–0.92
Group: countries
 England 397 0.90 0.87 to 0.97
 France 257 0.81 0.78 to 0.85
 Spain 186 0.89 0.85 to 0.93
 Poland 163 0.89 0.85 to 0.92
 Greece 133 0.89 0.85 to 0.94
 Germany 125 0.81 0.75 to 0.86
 Norway 110 0.71 0.63 to 0.78
 Portugal 106 0.82 0.76 to 0.89
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Conclusion
In very elderly ICU patients, the CFS has a high compli-
ance rate and exhibits high overall inter-rater agreement 
with a weighted kappa analysis of 0.86. Furthermore, 
there are minor variations in performance across dif-
ferent health care professionals, countries and source of 
data. We found the best agreement using raters from the 
same health care professionals, but with no difference 
between pair of nurses or physicians. To determine CFS, 
caution should be used to rely on the elderly ICU patients 
as the sole source of information.
Frailty assessment should be routine in the critical ill 
elderly patients, and the CFS is a good instrument in this 
respect, and will give a more holistic impression of the 
patient´s condition prior to admission.
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